PTC Therapeutics (PTCT) PT Raised to $95 at Wells Fargo
Tweet
Share
E-mailGet Alerts PTCT Hot Sheet
Price: $84.41 +2.78%
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 54
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 54
Join SI Premium – FREE
Wells Fargo analyst Ben Burnett raised the price target on PTC Therapeutics (NASDAQ: PTCT) to $95.00 (from $86.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Morgan Stanley Upgrades Telecom Argentina (TEO) to Overweight
- Syngene International Ltd (SYNG:IN) PT Lowered to INR735 at Macquarie
- National Australia Bank Ltd. (NAB:AU) (NABZY) PT Lowered to AUD47.50 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
